EXTH-46. SCHLAFEN11 IS A POWERFUL BIOMARKER OF CHEMOSENSITIVITY IN MEDULLOBLASTOMAS
Manabu Natsumeda(Niigata University), Charles G. Eberhart(Johns Hopkins University), Jun Watanabe(Niigata University), Yves Pommier(National Cancer Institute), Yoshihiro Tsukamoto(Niigata University), Eric H. Raabe(Johns Hopkins University), Masayasu Okada(Niigata University Medical and Dental Hospital), Makoto Oishi(Niigata University), Célio Pouponnot(Université Paris-Sud), Junko Murai(Ehime University), Kensuke Tateishi(Yokohama City University Medical Center), Satoru Osuka(University of Alabama at Birmingham), Akiyoshi Kakita(Niigata University), Haruhiko Takahashi(Nara Medical University), Satoshi Nakata(Gunma University)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Structure-based classification of tauopathies
|Nature|2021|916
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711